- Supported exchanges /
- STU /
- CLM.STU
Clearside Biomedical Inc. (CLM STU) stock market data APIs
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Clearside Biomedical Inc. Financial Data Overview
1.03 | |
1 | |
- | |
1.03 | |
1 | |
0.615-1.83 | |
74 746 K | |
74 746 K | |
7 524 K | |
-0.16 | |
2.355 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Clearside Biomedical Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 7 524 K
- EBITDA -25 660 000
- Earnings Per Share -0.46
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Clearside Biomedical Inc. Earnings via APIs
- Latest Release 2023-03-09
- EPS/Forecast -0.13
Get Clearside Biomedical Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: